Biotech Stocks See Major Selling Pressure
Tweet
Share
E-mail
Get Alerts BIIB Hot Sheet
Join SI Premium – FREE
Traders are paying close attention to today's selling pressure in biotech, which comes despite a bullish analyst call on group leader Biogen (NASDAQ: BIIB). Biotech stocks, as represented by iShares Nasdaq Biotechnology (NYSE: IBB), are down 2.9% currently. Biogen, after trading up 4% earlier, is down 1%.
Biotech has been a leading sector, so the sell-off is concerning for momentum investors.
Biotech has been a leading sector, so the sell-off is concerning for momentum investors.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Biogen (BIIB) PT Lowered to $222 at Morgan Stanley
- SK Hynix CEO: memory chip shortage may persist beyond 2030, 2027 will be the worst year
- Netflix eyes Letterboxd acquisition, Variety reports, citing Puck
Create E-mail Alert Related Categories
ETFs, Momentum Movers, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
